NewEdge Advisors LLC Has $84.39 Million Position in GE HealthCare Technologies Inc. $GEHC

Posted by Brian Himes on Sep 9th, 2026

NewEdge Advisors LLC lifted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 50.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,318,329 shares of the company’s stock after purchasing an additional 441,257 shares during the period. NewEdge Advisors LLC owned 0.29% of GE HealthCare Technologies worth $84,386,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the business. Banque Cantonale Vaudoise increased its position in GE HealthCare Technologies by 16,539.1% during the first quarter. Banque Cantonale Vaudoise now owns 25,957 shares of the company’s stock worth $1,849,000 after acquiring an additional 25,801 shares during the period. Allstate Corp boosted its holdings in GE HealthCare Technologies by 100.3% in the 4th quarter. Allstate Corp now owns 32,688 shares of the company’s stock valued at $2,681,000 after purchasing an additional 16,365 shares during the period. Auto Owners Insurance Co grew its position in GE HealthCare Technologies by 9,525.4% in the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after purchasing an additional 33,629,559 shares during the last quarter. Northside Capital Management LLC grew its position in GE HealthCare Technologies by 26.5% in the 2nd quarter. Northside Capital Management LLC now owns 241,923 shares of the company’s stock worth $15,485,000 after purchasing an additional 50,634 shares during the last quarter. Finally, Boston Partners increased its holdings in shares of GE HealthCare Technologies by 21.7% during the 4th quarter. Boston Partners now owns 4,659,562 shares of the company’s stock worth $382,223,000 after purchasing an additional 830,626 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Down 3.0%

NASDAQ GEHC opened at $66.78 on Wednesday. The firm has a market cap of $30.16 billion, a PE ratio of 15.32, a price-to-earnings-growth ratio of 1.82 and a beta of 0.70. GE HealthCare Technologies Inc. has a one year low of $58.75 and a one year high of $89.77. The stock’s 50 day simple moving average is $68.42 and its 200 day simple moving average is $68.72. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.26 and a quick ratio of 0.97.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.09. The firm had revenue of $5.29 billion during the quarter, compared to the consensus estimate of $5.26 billion. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%.The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.06 EPS. As a group, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.93 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Friday, July 24th were issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend was Friday, July 24th. GE HealthCare Technologies’s payout ratio is currently 3.21%.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Hovde Group assumed coverage on shares of GE HealthCare Technologies in a research report on Friday, July 17th. They set a “market perform” rating and a $14.00 price objective for the company. Oppenheimer reissued an “outperform” rating on shares of GE HealthCare Technologies in a research report on Thursday, July 30th. UBS Group boosted their price target on GE HealthCare Technologies from $67.00 to $73.00 and gave the company a “neutral” rating in a research note on Friday, July 31st. Wells Fargo & Company upped their price target on GE HealthCare Technologies from $75.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, July 30th. Finally, Citigroup raised their price objective on GE HealthCare Technologies from $69.00 to $75.00 and gave the stock a “neutral” rating in a research report on Thursday, July 30th. Ten analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $77.73.

View Our Latest Analysis on GE HealthCare Technologies

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.